Vivani Medical Inc (VANI) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading signals or trends. It is better to hold off on investing in this stock at the moment.
The MACD is slightly positive but contracting, RSI is neutral at 42.468, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Support and resistance levels show limited upside potential in the short term, with a pivot at 1.165 and resistance at 1.236.

NULL identified. No recent news or significant insider or hedge fund activity.
Weak financial performance with no revenue growth, negative net income (-$6.53M), and no significant trading trends from insiders or hedge funds.
In Q3 2025, revenue remained at $0 with no YoY growth. Net income improved slightly by 8.09% YoY but remains negative at -$6.53M. EPS stayed at -0.11 with no improvement. Gross margin is 0%.
No analyst ratings or price target data available.